Human evidence is limited to a handful of small studies for BPC-157 and even less for the rest, long-term safety data doesnt exist, and the compounds sit in a regulatory grey zone that may shift through 2026
Thats why support matters
If you experience severe hypoglycemia, persistent nausea, or significant changes in digestion after adding berberine to your semaglutide therapy, contact your healthcare provider immediately
The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on Chinese patients
Called liraglutide, the company began clinical testing of the drug for diabetes in 1997
Active or recent malignancy is treated as a hard contraindication in the clinical literature, and a history of hormone-sensitive cancer warrants specialist input